Patent · US Expired

Morpholine derivatives as antagonists of orexin receptors

US6943160B2 · kind B2 · utility

10Cited by
12References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 22, 2001
Grant dateSep 13, 2005
Priority date—
Expiry dateNov 22, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to morpholine derivatives of formula (I) and their use as antagonists of orexin receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.